541096 — Bharat Parenterals Share Price
0.000.00%
Last trade - 00:00- IN₹6.48bn
- IN₹7.54bn
- IN₹2.57bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.29 | ||
| Price to Tang. Book | 2.3 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.13 | ||
| EV to EBITDA | 508 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.54% | ||
| Return on Equity | -3.44% | ||
| Operating Margin | -9.59% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,279.65 | 2,046.4 | 2,120.15 | 2,179.82 | 2,573.61 | n/a | n/a | 3.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +14.22 | -15.39 | +5.8 | -26.04 | -10.12 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. It has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others.
Directors
- Bharat Desai CHM
- Jignesh Shah CFO
- Lubhanshi Jhalani CCO
- Hemang Shah EDR (52)
- Shailesh Gabhawala NID (58)
- Mukesh Patel NID (53)
- Sanjay Shah NID (44)
- Zankhana Sheth NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 3rd, 1992
- Public Since
- March 21st, 2018
- No. of Employees
- 363
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 6,891,963
- Address
- 144-146VILL Haripura Ta Savli, VADODARA, 391520
- Web
- https://bplindia.in/
- Phone
- +91 2667251680
- Auditors
- CNK & Associates LLP
Upcoming Events for 541096
Bharat Parenterals Ltd Annual Shareholders Meeting
Q1 2026 Bharat Parenterals Ltd Earnings Release
Q2 2026 Bharat Parenterals Ltd Earnings Release
Similar to 541096
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Bharat Parenterals share price?
As of Today at 19:33 UTC, shares in Bharat Parenterals are trading at IN₹940.00. This share price information is delayed by 15 minutes.
How has the Bharat Parenterals share price performed this year?
Shares in Bharat Parenterals last closed at IN₹940.00 and the price had moved by -44.72% over the past 365 days. In terms of relative price strength the Bharat Parenterals share price has underperformed the S&P BSE 100 Index by -47.93% over the past year.
What are the analyst and broker recommendations for Bharat Parenterals?
There is no consensus recommendation for this security.
Find out moreWhat is the Bharat Parenterals dividend yield?
The Bharat Parenterals dividend yield is 0.11% based on the trailing twelve month period.
Does Bharat Parenterals pay a dividend?
Last year, Bharat Parenterals paid a total dividend of IN₹1.00, and it currently has a trailing dividend yield of 0.11%. We do not have any data on when Bharat Parenterals is to next pay dividends.
When does Bharat Parenterals next pay dividends?
We do not have data on when Bharat Parenterals is to next pay dividends. The historic dividend yield on Bharat Parenterals shares is currently 0.11%.
How do I buy Bharat Parenterals shares?
To buy shares in Bharat Parenterals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bharat Parenterals?
As of the previous close price of IN₹940.00, shares in Bharat Parenterals had a market capitalisation of IN₹6.48bn.
Where are Bharat Parenterals shares listed?
Here are the trading details for Bharat Parenterals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 541096
What kind of share is Bharat Parenterals?
Based on an overall assessment of its quality, value and momentum Bharat Parenterals is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bharat Parenterals share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Bharat Parenterals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bharat Parenterals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -27.55%.
As of the last closing price of IN₹940.00, shares in Bharat Parenterals were trading -33.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bharat Parenterals PE Ratio?
The Bharat Parenterals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹940.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bharat Parenterals?
Bharat Parenterals' management team is headed by:
- Bharat Desai - CHM
- Jignesh Shah - CFO
- Lubhanshi Jhalani - CCO
- Hemang Shah - EDR
- Shailesh Gabhawala - NID
- Mukesh Patel - NID
- Sanjay Shah - NID
- Zankhana Sheth - NID